Long-Term Functional Outcomes in Immunoglobulin-Treated Multifocal Motor Neuropathy Evaluated Through the...

Area of Science:

• Neurology
• Immunology
• Clinical Therapeutics

Background:

• Long-term functional outcomes for multifocal motor neuropathy (MMN) patients receiving immunoglobulin (Ig) therapy remain unclear.
• MMN is a rare autoimmune disorder affecting peripheral nerves.

Purpose of the Study:

• To evaluate long-term functional outcomes in MMN patients treated with immunoglobulin therapy.
• To investigate the relationship between immunoglobulin dosing, dose adjustments, and functional status.

Main Methods:

• Retrospective study of MMN patients from two UK neuromuscular centers.
• Collected MMN-Rasch-built Overall Disability Scale (MMN-RODS) scores and immunoglobulin doses.
• Analyzed changes in MMN-RODS scores following dose alterations.

Main Results:

• 90.6% of 32 MMN patients showed improved MMN-RODS scores over a mean of 6.2 years.
• Mean MMN-RODS scores significantly improved (p < 0.001).
• Immunoglobulin dose dependency was observed, with higher doses and incremental adjustments correlating with better outcomes; significant inter-center variations in dosing and response were noted.

Conclusions:

• Individualized immunoglobulin dosing leads to sustained functional improvement in most MMN patients over the long term.
• Significant variations in dosing and dose dependency suggest patient- and physician-related factors influencing treatment response require further investigation.